Car T Cell Therapy Market

Home Healthcare And Pharmaceutical Car T Cell Therapy Market

CAR-T Cell Therapy Market, By Drug Indication (Axicabtagene Ciloleucel (Yescarta), Brexucabtagene Autoleucel (Tecartus), Ciltacabtagene Autoleucel (Carvykti), Idecabtagene Vicleucel (Abecma), Lisocabtagene Maraleucel (Breyanzi), Tisagenlecleucel (Kymriah), Others); By Indication (Acute Lymphoblastic Leukemia, Non-Hodgkin Lymphoma, Multiple Myeloma); By End User (Hospitals, Oncology Treatment Centers); By Region (North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA)), Global Trend Analysis, Competitive Landscape & Forecast, 2019–2030

Published Date: October 2024
Report ID: BWC24781
Available Format: PDF
Page: 418

Report Overview

An increasing number of cancer incidents, a spurring demand for targeted and personalized therapies, adoption of advancements in CAR-T technology, and growing number of clinical trial programs are expected to drive Global CAR-T Cell Therapy Market during the forecast period between 2024 and 2030.

Global CAR-T Cell Therapy Market – Industry Trends & Forecast Report, 2030

Global CAR-T Cell Therapy Market size by value was estimated at USD 9.11 billion in 2023. During the forecast period between 2024 and 2030, Global CAR-T Cell Therapy Market size is expected to expand at a CAGR of 30.20% reaching a value of USD 56.80 billion by 2030. The increasing prevalence of cancer necessitates innovative treatments, boosting demand for CAR-T therapies. Advancements in CAR-T technology enhance treatment efficacy and safety. A growing demand for targeted and personalized therapies further propels market growth. Additionally, rising clinical trial activities and supportive regulatory frameworks encourage research and development, fostering the expansion of Global CAR-T Cell Therapy Market during the period in analysis.

CAR-T Cell Therapy Market

CAR-T Cell Therapy – Overview

CAR-T cell therapy is an advanced treatment for certain types of leukemia. This includes the elimination of a patient’s T cells, genetic manipulation to express chimeric antigen receptors (CARs) that target cancer cells, and reintroduction into the patient. These modified T cells can effectively identify and destroy cancer cells. This shows promising results from generic medicine, especially where other treatments have failed.

Global CAR-T Cell Therapy Market

Growth Drivers

Increasing Prevalence of Cancer

Rising incidence of cancer across the globe is driving Global CAR-T Cell Therapy Market. As the incidence of cancer rises, so does the need for new and effective treatments. CAR-T cell therapy, with a targeted approach, offers promising results for patients with several cancers. This demand for advanced therapies drives research and development, leading to more clinical trials and regulatory approvals, and driving market growth.

Challenges

High Cost of CAR-T Cell Therapy

High cost of CAR-T cell therapy significantly restrains the market growth. These treatments, which range in price from USD 300,000 to USD 600,000, can exceed USD 100,000 when combined with clinical care and adverse reactions. The complicated process and extensive clinical trials contribute to this high cost. Consequently, the financial burden on patients and healthcare systems limits their uptake, posing a significant challenge to market expansion.

Impact of Escalating Geopolitical Tensions on Global CAR-T Cell Therapy Market

Intensifying and further spreading of geopolitical tensions among countries across the major regions could significantly impact Global CAR-T Cell Therapy Market. Supply chain constraints and trade constraints delay the availability of essential raw materials and inputs. The high cost of these products further complicates the production budget. Political instability can affect regulatory approval and clinical trial processes, leading to delays in bringing new therapies to market. Further, increased geopolitical risk can deter investment in research and development, slowing down innovation. All of these challenges impede market growth and access, making it difficult for patients to access advanced CAR T-cell therapy.

Global CAR-T Cell Therapy Market

Segmental Coverage

Global CAR-T Cell Therapy Market – By Indication

By indication, Global CAR-T Cell Therapy Market is divided into Acute Lymphoblastic Leukemia, Non-Hodgkin Lymphoma, and Multiple Myeloma segments. Non-Hodgkin Lymphoma (NHL) segment holds the largest market share of Global CAR-T Cell Therapy Market by indication. The dominance is due to the high prevalence of NHL and the effectiveness of CAR-T therapies in treating this type of cancer. The success of CAR-T cell therapies in clinical trials and their approval for treating relapsed or refractory NHL contribute to the segment's dominance.

CAR-T Cell Therapy Market Size

Global CAR-T Cell Therapy Market – By End User

Based on end user, Global CAR-T Cell Therapy Market is divided into Hospitals and Oncology Treatment Centers segments. The hospitals segment holds a larger market share of Global CAR-T Cell Therapy Market by end user, due to hospitals’ advanced infrastructure, availability of specialized medical professionals, and comprehensive care facilities. They are the primary centers for administering CAR-T cell therapies, managing complex cases, and providing necessary post-treatment care. This dominance is driven by the need for highly controlled environments to ensure patient safety and treatment efficacy.

CAR-T Cell Therapy Market Growth

Global CAR-T Cell Therapy Market – By Region

Geographically, Global CAR-T Cell Therapy Market is divided into North America, Europe, Asia Pacific (APAC), Latin America (LATAM), and Middle East and Africa (MEA). North America is the leading region of Global CAR-T Cell Therapy Market. This region holds the largest market share due to advanced healthcare infrastructure, high investment in research and development, and the presence of key market players. Additionally, the high prevalence of cancer and supportive regulatory frameworks further drive the adoption of CAR-T cell therapies in North America.

CAR-T Cell Therapy Market Share

Competitive Landscape

Key players in the highly competitive Global CAR-T Cell Therapy Market include Bristol-Myers Squibb, Sorrento Therapeutics, Inc., Celgene Corporation, Merck & Co., Inc., Novartis AG, Celyad Oncology, Juno Therapeutics, Inc., Autolus Therapeutics, Cellectis, Miltenyi Biotech, Intellia Therapeutics, and Pfizer, Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

In October 2023 - ImmunoACT gained approval from the Central Drugs Standard Control Organization for its CAR-T cell therapy for treating relapsed/refractory B-cell lymphomas and leukemia in India.

Scope of the Report

Attributes	Details
Years Considered	Historical Data – 2019–2023
	Base Year – 2023
	Estimated Year – 2024
	Forecast Period – 2024–2030
Facts Covered	Revenue in USD Billion
Market Coverage	North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA)
Product/Service Segmentation	Drug Indication, Indication, End User, Region
Key Players	Bristol-Myers Squibb, Sorrento Therapeutics, Inc., Celgene Corporation, Merck & Co., Inc., Novartis AG, Celyad Oncology, Juno Therapeutics, Inc., Autolus Therapeutics, Cellectis, Miltenyi Biotech, Intellia Therapeutics, Pfizer, Inc.

By Drug Indication

Axicabtagene Ciloleucel (Yescarta)
Brexucabtagene Autoleucel (Tecartus)
Ciltacabtagene Autoleucel (Carvykti)
Idecabtagene Vicleucel (Abecma)
Lisocabtagene Maraleucel (Breyanzi)
Tisagenlecleucel (Kymriah)
Others

By Indication

Acute Lymphoblastic Leukemia
Non-Hodgkin Lymphoma
Multiple Myeloma

By End User

Hospitals
Oncology Treatment Centers

By Region

North America
Europe
Asia Pacific (APAC)
Latin America (LATAM)
Middle East and Africa (MEA)

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Executive Summary
Global CAR-T Cell Therapy Market Insights
1. End User Value Chain Analysis
2. DROC Analysis
  1. Growth Drivers
    1. Rising prevalence of cancer
    2. Continuous advancements in cell engineering and genetic modification techniques
    3. Favorable regulatory landscape: for CAR-T cell therapy
    4. Growing interest from pharmaceutical companies, biotech firms, and investors
  2. Restraints
    1. High costs of CAR-T cell therapy
    2. Limited availability and access to CAR-T cell therapy is often restricted to a limited number of patients.
    3. Potential side effects associated with CAR-T cell therapy
  3. Opportunities
    1. Expansion into new indications
    2. Combining CAR-T cell therapy with other treatments
    3. Advancements in genomics and personalized medicine
  4. Challenges
    1. Manufacturing challenges associated with the production of CAR-T cell therapies
    2. Ensuring adequate reimbursement for CAR-T cell therapy
3. Technological Advancements/Recent Developments
4. Regulatory Framework
5. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Global CAR-T Cell Therapy Market: Marketing Strategies
Global CAR-T Cell Therapy Market: Pricing Analysis
Global CAR-T Cell Therapy Market: Geography Analysis
1. Global CAR-T Cell Therapy Market, Geographical Analysis, 2023
2. Global CAR-T Cell Therapy, Market Attractiveness Analysis, 2024–2030
Global CAR-T Cell Therapy Market Overview
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Drug Indication
    1. Axicabtagene Ciloleucel (Yescarta)
    2. Brexucabtagene Autoleucel (Tecartus)
    3. Ciltacabtagene Autoleucel (Carvykti)
    4. Idecabtagene Vicleucel (Abecma)
    5. Lisocabtagene Maraleucel (Breyanzi)
    6. Tisagenlecleucel (Kymriah)
    7. Others
  2. By Indication
    1. Acute Lymphoblastic Leukemia
    2. Non-Hodgkin Lymphoma
    3. Multiple Myeloma
  3. By End User
    1. Hospitals
    2. Oncology Treatment Centers
  4. By Region
    1. North America
    2. Europe
    3. Asia Pacific (APAC)
    4. Latin America (LATAM)
    5. Middle East and Africa (MEA)
North America CAR-T Cell Therapy Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Drug Indication
  2. By Indication
  3. By End User
  4. By Country
    1. United States
      1. By Drug Indication
      2. By Indication
      3. By End User
    2. Canada
      1. By Drug Indication
      2. By Indication
      3. By End User
Europe CAR-T Cell Therapy Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Drug Indication
  2. By Indication
  3. By End User
  4. By Country
    1. Germany
      1. By Drug Indication
      2. By Indication
      3. By End User
    2. United Kingdom
      1. By Drug Indication
      2. By Indication
      3. By End User
    3. Italy
      1. By Drug Indication
      2. By Indication
      3. By End User
    4. France
      1. By Drug Indication
      2. By Indication
      3. By End User
    5. Spain
      1. By Drug Indication
      2. By Indication
      3. By End User
    6. Belgium
      1. By Drug Indication
      2. By Indication
      3. By End User
    7. Russia
      1. By Drug Indication
      2. By Indication
      3. By End User
    8. The Netherlands
      1. By Drug Indication
      2. By Indication
      3. By End User
    9. Rest of Europe
      1. By Drug Indication
      2. By Indication
      3. By End User
Asia Pacific CAR-T Cell Therapy Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Drug Indication
  2. By Indication
  3. By End User
  4. By Country
    1. China
      1. By Drug Indication
      2. By Indication
      3. By End User
    2. India
      1. By Drug Indication
      2. By Indication
      3. By End User
    3. Japan
      1. By Drug Indication
      2. By Indication
      3. By End User
    4. South Korea
      1. By Drug Indication
      2. By Indication
      3. By End User
    5. Australia & New Zealand
      1. By Drug Indication
      2. By Indication
      3. By End User
    6. Indonesia
      1. By Drug Indication
      2. By Indication
      3. By End User
    7. Malaysia
      1. By Drug Indication
      2. By Indication
      3. By End User
    8. Singapore
      1. By Drug Indication
      2. By Indication
      3. By End User
    9. Vietnam
      1. By Drug Indication
      2. By Indication
      3. By End User
    10. Rest of APAC
      1. By Drug Indication
      2. By Indication
      3. By End User
Latin America CAR-T Cell Therapy Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Drug Indication
  2. By Indication
  3. By End User
  4. By Country
    1. Brazil
      1. By Drug Indication
      2. By Indication
      3. By End User
    2. Mexico
      1. By Drug Indication
      2. By Indication
      3. By End User
    3. Argentina
      1. By Drug Indication
      2. By Indication
      3. By End User
    4. Peru
      1. By Drug Indication
      2. By Indication
      3. By End User
    5. Rest of LATAM
      1. By Drug Indication
      2. By Indication
      3. By End User
Middle East and Africa CAR-T Cell Therapy Market
1. Market Size & Forecast, 2019–2030
  1. By Value (USD Billion)
2. Market Share & Forecast
  1. By Drug Indication
  2. By Indication
  3. By End User
  4. By Country
    1. Saudi Arabia
      1. By Drug Indication
      2. By Indication
      3. By End User
    2. UAE
      1. By Drug Indication
      2. By Indication
      3. By End User
    3. Qatar
      1. By Drug Indication
      2. By Indication
      3. By End User
    4. Kuwait
      1. By Drug Indication
      2. By Indication
      3. By End User
    5. South Africa
      1. By Drug Indication
      2. By Indication
      3. By End User
    6. Nigeria
      1. By Drug Indication
      2. By Indication
      3. By End User
    7. Algeria
      1. By Drug Indication
      2. By Indication
      3. By End User
    8. Rest of MEA
      1. By Drug Indication
      2. By Indication
      3. By End User
Competitive Landscape
1. List of Key Players and Their Offerings
2. Global CAR-T Cell Therapy Company Market Share Analysis, 2023
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
Impact of Escalating Geopolitical Tensions on Global CAR-T Cell Therapy Market
Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
1. Bristol-Myers Squibb
2. Sorrento Therapeutics, Inc.
3. Celgene Corporation
4. Merck & Co., Inc.
5. Novartis AG
6. Celyad Oncology
7. Juno Therapeutics, Inc.
8. Autolus Therapeutics
9. Cellectis
10. Miltenyi Biotech
11. Intellia Therapeutics
12. Pfizer, Inc.
13. Other Prominent Players
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1 Global CAR-T Cell Therapy Segmentation

Figure 2 Global CAR-T Cell Therapy Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2023

Figure 4 Global CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 5 Global CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 6 Global CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 7 Global CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 8 Global CAR-T Cell Therapy Market Share, By Region, By Value (USD Billion), 2019–2030

Figure 9 North America CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 10 North America CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 11 North America CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 12 North America CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 13 North America CAR-T Cell Therapy Market Share, By Country, By Value (USD Billion), 2019–2030

Figure 14 United States CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 15 United States CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 16 United States CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 17 United States CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 18 Canada CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 19 Canada CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 20 Canada CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 21 Canada CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 22 Europe CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 23 Europe CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 24 Europe CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 25 Europe CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 26 Europe CAR-T Cell Therapy Market Share, By Country, By Value (USD Billion), 2019–2030

Figure 27 Germany CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 28 Germany CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 29 Germany CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 30 Germany CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 31 United Kingdom CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 32 United Kingdom CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 33 United Kingdom CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 34 United Kingdom CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 35 Italy CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 36 Italy CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 37 Italy CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 38 Italy CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 39 France CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 40 France CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 41 France CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 42 France CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 43 Spain CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 44 Spain CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 45 Spain CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 46 Spain CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 47 Belgium CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 48 Belgium CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 49 Belgium CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 50 Belgium CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 51 Russia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 52 Russia CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 53 Russia CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 54 Russia CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 55 The Netherlands CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 56 The Netherlands CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 57 The Netherlands CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 58 The Netherlands CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 59 Rest of Europe CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 60 Rest of Europe CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 61 Rest of Europe CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 62 Rest of Europe CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 63 Asia Pacific CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 64 Asia Pacific CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 65 Asia Pacific CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 66 Asia Pacific CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 67 Asia Pacific CAR-T Cell Therapy Market Share, By Country, By Value (USD Billion), 2019–2030

Figure 68 China CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 69 China CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 70 China CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 71 China CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 72 India CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 73 India CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 74 India CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 75 India CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 76 Japan CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 77 Japan CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 78 Japan CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 79 Japan CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 80 South Korea CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 81 South Korea CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 82 South Korea CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 83 South Korea CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 84 Australia & New Zealand CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 85 Australia & New Zealand CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 86 Australia & New Zealand CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 87 Australia & New Zealand CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 88 Indonesia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 89 Indonesia CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 90 Indonesia CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 91 Indonesia CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 92 Malaysia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 93 Malaysia CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 94 Malaysia CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 95 Malaysia CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 96 Singapore CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 97 Singapore CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 98 Singapore CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 99 Singapore CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 100 Vietnam CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 101 Vietnam CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 102 Vietnam CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 103 Vietnam CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 104 Rest of APAC CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 105 Rest of APAC CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 106 Rest of APAC CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 107 Rest of APAC CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 108 Latin America CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 109 Latin America CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 110 Latin America CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 111 Latin America CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 112 Latin America CAR-T Cell Therapy Market Share, By Country, By Value (USD Billion), 2019–2030

Figure 113 Brazil CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 114 Brazil CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 115 Brazil CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 116 Brazil CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 117 Mexico CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 118 Mexico CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 119 Mexico CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 120 Mexico CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 121 Argentina CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 122 Argentina CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 123 Argentina CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 124 Argentina CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 125 Peru CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 126 Peru CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 127 Peru CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 128 Peru CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 129 Rest of LATAM CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 130 Rest of LATAM CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 131 Rest of LATAM CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 132 Rest of LATAM CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 133 Middle East and Africa CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 134 Middle East and Africa CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 135 Middle East and Africa CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 136 Middle East and Africa CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 137 Middle East and Africa CAR-T Cell Therapy Market Share, By Country, By Value (USD Billion), 2019–2030

Figure 138 Saudi Arabia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 139 Saudi Arabia CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 140 Saudi Arabia CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 141 Saudi Arabia CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 142 UAE CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 143 UAE CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 144 UAE CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 145 UAE CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 146 Qatar CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 147 Qatar CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 148 Qatar CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 149 Qatar CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 150 Kuwait CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 151 Kuwait CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 152 Kuwait CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 153 Kuwait CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 154 South Africa CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 155 South Africa CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 156 South Africa CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 157 South Africa CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 158 Nigeria CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 159 Nigeria CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 160 Nigeria CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 161 Nigeria CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 162 Algeria CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 163 Algeria CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 164 Algeria CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 165 Algeria CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

Figure 166 Rest of MEA CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Figure 167 Rest of MEA CAR-T Cell Therapy Market Share, By Drug Indication, By Value (USD Billion), 2019–2030

Figure 168 Rest of MEA CAR-T Cell Therapy Market Share, By Indication, By Value (USD Billion), 2019–2030

Figure 169 Rest of MEA CAR-T Cell Therapy Market Share, By End User, By Value (USD Billion), 2019–2030

List of Tables

Table 1 Global CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 2 Global CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 3 Global CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 4 Global CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 5 Global CAR-T Cell Therapy Market Size, By Region, By Value (USD Billion), 2019–2030

Table 6 North America CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 7 North America CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 8 North America CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 9 North America CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 10 North America CAR-T Cell Therapy Market Size, By Country, By Value (USD Billion), 2019–2030

Table 11 United States CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 12 United States CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 13 United States CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 14 United States CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 15 Canada CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 16 Canada CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 17 Canada CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 18 Canada CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 19 Europe CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 20 Europe CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 21 Europe CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 22 Europe CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 23 Europe CAR-T Cell Therapy Market Size, By Country, By Value (USD Billion), 2019–2030

Table 24 Germany CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 25 Germany CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 26 Germany CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 27 Germany CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 28 United Kingdom CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 29 United Kingdom CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 30 United Kingdom CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 31 United Kingdom CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 32 Italy CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 33 Italy CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 34 Italy CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 35 Italy CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 36 France CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 37 France CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 38 France CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 39 France CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 40 Spain CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 41 Spain CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 42 Spain CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 43 Spain CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 44 Belgium CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 45 Belgium CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 46 Belgium CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 47 Belgium CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 48 Russia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 49 Russia CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 50 Russia CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 51 Russia CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 52 The Netherlands CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 53 The Netherlands CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 54 The Netherlands CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 55 The Netherlands CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 56 Rest of Europe CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 57 Rest of Europe CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 58 Rest of Europe CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 59 Rest of Europe CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 60 Asia Pacific CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 61 Asia Pacific CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 62 Asia Pacific CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 63 Asia Pacific CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 64 Asia Pacific CAR-T Cell Therapy Market Size, By Country, By Value (USD Billion), 2019–2030

Table 65 China CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 66 China CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 67 China CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 68 China CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 69 India CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 70 India CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 71 India CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 72 India CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 73 Japan CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 74 Japan CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 75 Japan CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 76 Japan CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 77 South Korea CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 78 South Korea CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 79 South Korea CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 80 South Korea CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 81 Australia & New Zealand CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 82 Australia & New Zealand CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 83 Australia & New Zealand CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 84 Australia & New Zealand CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 85 Indonesia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 86 Indonesia CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 87 Indonesia CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 88 Indonesia CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 89 Malaysia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 90 Malaysia CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 91 Malaysia CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 92 Malaysia CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 93 Singapore CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 94 Singapore CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 95 Singapore CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 96 Singapore CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 97 Vietnam CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 98 Vietnam CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 99 Vietnam CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 100 Vietnam CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 101 Rest of APAC CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 102 Rest of APAC CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 103 Rest of APAC CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 104 Rest of APAC CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 105 Latin America CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 106 Latin America CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 107 Latin America CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 108 Latin America CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 109 Latin America CAR-T Cell Therapy Market Size, By Country, By Value (USD Billion), 2019–2030

Table 110 Brazil CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 111 Brazil CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 112 Brazil CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 113 Brazil CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 114 Mexico CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 115 Mexico CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 116 Mexico CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 117 Mexico CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 118 Argentina CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 119 Argentina CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 120 Argentina CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 121 Argentina CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 122 Peru CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 123 Peru CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 124 Peru CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 125 Peru CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 126 Rest of LATAM CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 127 Rest of LATAM CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 128 Rest of LATAM CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 129 Rest of LATAM CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 130 Middle East and Africa CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 131 Middle East and Africa CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 132 Middle East and Africa CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 133 Middle East and Africa CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 134 Middle East and Africa CAR-T Cell Therapy Market Size, By Country, By Value (USD Billion), 2019–2030

Table 135 Saudi Arabia CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 136 Saudi Arabia CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 137 Saudi Arabia CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 138 Saudi Arabia CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 139 UAE CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 140 UAE CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 141 UAE CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 142 UAE CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 143 Qatar CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 144 Qatar CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 145 Qatar CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 146 Qatar CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 147 Kuwait CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 148 Kuwait CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 149 Kuwait CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 150 Kuwait CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 151 South Africa CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 152 South Africa CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 153 South Africa CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 154 South Africa CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 155 Nigeria CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 156 Nigeria CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 157 Nigeria CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 158 Nigeria CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 159 Algeria CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 160 Algeria CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 161 Algeria CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 162 Algeria CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 163 Rest of MEA CAR-T Cell Therapy Market Size, By Value (USD Billion), 2019–2030

Table 164 Rest of MEA CAR-T Cell Therapy Market Size, By Drug Indication, By Value (USD Billion), 2019–2030

Table 165 Rest of MEA CAR-T Cell Therapy Market Size, By Indication, By Value (USD Billion), 2019–2030

Table 166 Rest of MEA CAR-T Cell Therapy Market Size, By End User, By Value (USD Billion), 2019–2030

Table 167 Bristol-Myers Squibb Company Overview

Table 168 Bristol-Myers Squibb Financial Overview

Table 169 Sorrento Therapeutics, Inc. Company Overview

Table 170 Sorrento Therapeutics, Inc. Financial Overview

Table 171 Celgene Corporation Company Overview

Table 172 Celgene Corporation Financial Overview

Table 173 Merck & Co., Inc. Company Overview

Table 174 Merck & Co., Inc. Financial Overview

Table 175 Novartis AG Company Overview

Table 176 Novartis AG Financial Overview

Table 177 Celyad Oncology Company Overview

Table 178 Celyad Oncology Financial Overview

Table 179 Juno Therapeutics, Inc. Company Overview

Table 180 Juno Therapeutics, Inc. Financial Overview

Table 181 Autolus Therapeutics Company Overview

Table 182 Autolus Therapeutics Financial Overview

Table 183 Cellectis Company Overview

Table 184 Cellectis Financial Overview

Table 185 Miltenyi Biotech Company Overview

Table 186 Miltenyi Biotech Financial Overview

Table 187 Intellia Therapeutics Company Overview

Table 188 Intellia Therapeutics Financial Overview

Table 189 Pfizer, Inc. Company Overview

Table 190 Pfizer, Inc. Financial Overview

Market Segmentation

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Note: Please share the corporate email address for faster response

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. What is the current Market size of Global CAR-T Cell Therapy Market by value?

Ans: Global CAR-T Cell Therapy Market size by value was estimated at USD 9.11 billion in 2023.

2. What is the expected growth rate of Global CAR-T Cell Therapy Market by value during the forecast period?

Ans: Global CAR-T Cell Therapy Market by value is expected to grow at a CAGR of 30.20% during the forecast period between 2024 and 2030.

3. What is the forecast value of Global CAR-T Cell Therapy Market size by 2030?

Ans: Global CAR-T Cell Therapy Market size is forecast to reach a value of USD 56.80 billion by 2030.

4. What are the major factors driving the growth of Global CAR-T Cell Therapy Market?

Ans: The growth of Global CAR-T Cell Therapy Market is primarily driven by growing incidence of cancer, demand for targeted and personalized therapies, advances in CAR-T technology, and increasing clinical trial activities.

5. Name the leading region of Global CAR-T Cell Therapy Market.

Ans: North America is the leading region of Global CAR-T Cell Therapy Market.

6. Name the key players in Global CAR-T Cell Therapy Market.

Ans: Key players in Global CAR-T Cell Therapy Market include Bristol-Myers Squibb, Sorrento Therapeutics, Inc., Celgene Corporation, Merck & Co., Inc., Novartis AG, Celyad Oncology, Juno Therapeutics, Inc., Autolus Therapeutics, Cellectis, Miltenyi Biotech, Intellia Therapeutics, and Pfizer, Inc.

PLACE AN ORDER

SINGLE USER LICENSE
$ 4850
GROUP LICENSE
$ 5750
ENTERPRISE LICENSE
$ 8150
EXCEL DATA PACK
$ 3250

Request for Sample

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.